Sandara Park denies drug claims, unfollows Park Bom after accusation

In response to Park Bom's recent Instagram letter accusing her of drug use, former 2NE1 member Sandara Park denied the claims, unfollowed Bom on social media, and wished her well, escalating tensions within the group.

This development follows Park Bom's March 4, 2026, handwritten letter (posted late March 3 UTC), where she accused Sandara of being caught in a 2010 drug case and framing Bom as a scapegoat to cover it up. See prior coverage: 'Park Bom accuses Sandara Park of framing her in 2010 drug scandal'.

On March 5, Sandara directly addressed the allegations on her social media: "I have never used drugs. I wish her well." She then unfollowed Park Bom's Instagram account, publicly signaling a rift. As of that afternoon, 2NE1 members CL and Minzy still followed Bom.

Sandara's representatives had already called the claims "groundless." The response comes amid 2NE1's 2024 reunion, with Bom on hiatus since August 2025 due to health issues and recent erratic social media activity, including debunked rumors.

Fans showed divided reactions: support for Sandara's boundaries, concern for Bom's well-being, and speculation on group dynamics. This incident revives questions about past scandals' impact on the group's legacy.

Related Articles

Dramatic illustration of Park Bom accusing 2NE1 bandmate Sandara Park of framing her in a 2010 drug scandal via deleted Instagram letter.
Image generated by AI

Park Bom accuses Sandara Park of framing her in 2010 drug scandal

Reported by AI Image generated by AI

On March 3, 2026, 2NE1 member Park Bom posted a now-deleted handwritten letter on Instagram, alleging that bandmate Sandara Park framed her as a drug addict to cover up her own drug issues from 2010. The post revisited Bom's past controversy involving Adderall medication for ADD treatment and named several former YG Entertainment figures. Representatives attributed the statement to Bom's unstable health condition amid her ongoing hiatus.

Comedian Park Na-rae is embroiled in workplace harassment allegations from former managers, putting multiple variety shows in jeopardy. MBC canceled filming for the new travel reality program 'Nado Sinna,' while her agency vowed legal action against the staff's financial demands. Park expressed significant emotional distress and acknowledged some responsibility.

Reported by AI

Manon Bannerman, a member of the global girl group KATSEYE under HYBE and Geffen Records, has announced a temporary hiatus to focus on her health and wellbeing. The joint statement from the labels confirms her absence from upcoming activities, including Lollapalooza and Coachella performances. Bannerman shared a reassuring message to fans on WeVerse.

North Korea's Kim Yo-jong demanded a detailed explanation from South Korea on January 11 over drone incursions accused on January 10, despite Seoul's denial of military involvement and launch of an investigation into possible private actors. The exchange risks escalating tensions on the Korean Peninsula.

Reported by AI

Kim Yo-jong, the powerful sister of North Korean leader Kim Jong-un, demanded that South Korea apologize for alleged drone incursions violating Pyongyang's sovereignty. Seoul has denied military involvement and launched an investigation into possible civilian origins, while pledging corresponding actions based on findings. Both sides have called for restored dialogue amid efforts to ease tensions.

A 24-year-old man named Ressa Rizky Rossano has sued singer Denada Tambunan at the Banyuwangi District Court for alleged neglect of an illegitimate child. He claims to be Denada's biological son and demands Rp7 billion in compensation for material and immaterial damages. Denada's former housekeeper denies the claim, stating she never knew of any other child.

Reported by AI

All five members of K-pop girl group NewJeans announced on November 12 their return to management agency ADOR. The decision follows a late October court ruling upholding their exclusive contract, ending a year-long legal dispute.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline